Philip Nadeau
Analyst
TD Cowan
Equibles does not estimate personal net worth.
About Philip Nadeau
Philip Nadeau is recorded as Analyst at TD Cowan. Philip Nadeau has spoken on 3 earnings calls across 3 companies, most recently for Vertex Pharmaceuticals Inc on August 3, 2026. Those appearances were for Vertex Pharmaceuticals Inc (VRTX), Biomarin Pharmaceutical Inc (BMRN) and Vir Biotechnology, Inc. (VIR). The companies whose calls Philip Nadeau spoke on are classified in the Healthcare sector.
Philip Nadeau on recent calls
“There's a lot of focus on the upcoming data from one of your competitors where we're going to get incremental sweat chloride reductions above trikafta. We're curious to hear Vertex's opinion on how you're going to interpret that data.”
“First, could you give an update on the ITC hearing? And in particular, we're curious to get your thoughts on the ITC pretrial brief that was recently posted online.”
“First, on 5500, you mentioned that there have been multiple doses tested since the data in January. We're wondering if you would care to comment on whether those additional doses have continued to suggest a dose response in efficacy in terms of PSA response rate and durability.”
Affiliation history
-
TD Cowan
Analyst
Transcript header (unverified)
Current